Tirdzniecība Dyadic International, Inc. - DYAI CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.1786 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
Nakts laika nodeva | 22:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Iepriekš. aizvērt* | 1.7638 |
Atvērt* | 1.744 |
Izmaiņas par 1 gadu* | -50.31% |
Dienas Diapazons* | 1.7157 - 1.812 |
52 ned Diapazons | 1.12-4.28 |
Vidējais apjoms (10 dienas) | 25.36K |
Vidējais apjoms (3 mēneši) | 1.05M |
Tirgus Kapitalizācija | 53.13M |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 28.56M |
Ieņēmumi | 2.50M |
EPS | -0.42 |
Dividende (Ienesīgums %) | N/A |
Beta | 0.59 |
Nākamās Peļņas Datums | Mar 27, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Feb 3, 2023 | 1.7157 | -0.0283 | -1.62% | 1.7440 | 1.8120 | 1.6763 |
Feb 2, 2023 | 1.7638 | 0.0093 | 0.53% | 1.7545 | 1.7640 | 1.7445 |
Feb 1, 2023 | 1.7447 | 0.0384 | 2.25% | 1.7063 | 1.7830 | 1.7063 |
Jan 31, 2023 | 1.6965 | 0.0092 | 0.55% | 1.6873 | 1.7640 | 1.6769 |
Jan 30, 2023 | 1.6873 | 0.0098 | 0.58% | 1.6775 | 1.6873 | 1.6384 |
Jan 27, 2023 | 1.6681 | 0.0387 | 2.38% | 1.6294 | 1.6681 | 1.6098 |
Jan 26, 2023 | 1.6394 | 0.0202 | 1.25% | 1.6192 | 1.6394 | 1.6192 |
Jan 25, 2023 | 1.6202 | 0.0590 | 3.78% | 1.5612 | 1.6202 | 1.5612 |
Jan 24, 2023 | 1.6104 | 0.0010 | 0.06% | 1.6094 | 1.6196 | 1.5523 |
Jan 23, 2023 | 1.5527 | 0.1155 | 8.04% | 1.4372 | 1.5625 | 1.4274 |
Jan 20, 2023 | 1.4568 | 0.0392 | 2.77% | 1.4176 | 1.4572 | 1.3890 |
Jan 19, 2023 | 1.4186 | 0.0202 | 1.44% | 1.3984 | 1.4284 | 1.3888 |
Jan 18, 2023 | 1.4090 | -0.1049 | -6.93% | 1.5139 | 1.5239 | 1.3894 |
Jan 17, 2023 | 1.5145 | -0.0190 | -1.24% | 1.5335 | 1.5723 | 1.4949 |
Jan 13, 2023 | 1.5433 | 0.0871 | 5.98% | 1.4562 | 1.5531 | 1.4562 |
Jan 12, 2023 | 1.4186 | 0.0585 | 4.30% | 1.3601 | 1.4186 | 1.3601 |
Jan 11, 2023 | 1.3803 | 0.0106 | 0.77% | 1.3697 | 1.3997 | 1.3603 |
Jan 10, 2023 | 1.3897 | 0.1253 | 9.91% | 1.2644 | 1.3994 | 1.2644 |
Jan 9, 2023 | 1.3038 | -0.0661 | -4.83% | 1.3699 | 1.3899 | 1.2740 |
Jan 6, 2023 | 1.3611 | 0.0865 | 6.79% | 1.2746 | 1.3611 | 1.2746 |
Dyadic International, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kopējie ienākumi | 0.59289 | 0.75842 | 1.29545 | 1.68108 | 1.60192 | 2.40383 |
Ienākumi | 0.59289 | 0.75842 | 1.29545 | 1.68108 | 1.60192 | 2.40383 |
Cost of Revenue, Total | 0.51616 | 0.6802 | 1.02728 | 1.4597 | 1.42493 | 1.94444 |
Bruto Peļņa | 0.07673 | 0.07822 | 0.26817 | 0.22138 | 0.17699 | 0.45939 |
Kopējie Darbības Izdevumi | 4.44813 | 3.52708 | 8.8879 | 10.9637 | 11.6276 | 17.1313 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 4.56212 | 5.03035 | 4.52268 | 5.51992 | 6.0848 | 6.69762 |
Pētniecība un Attīstība | 0.8856 | 2.2031 | 3.31716 | 3.95632 | 3.86812 | 8.39237 |
Procentu Izdevumi (Ienākumi) - Neto Darbība | 0.14734 | -0.24906 | 0.02078 | 0.02773 | 0.06235 | 0.09689 |
Neparedzēti Izdevumi (Ienākumi) | -2.1 | -4.35822 | 0 | |||
Other Operating Expenses, Total | 0.43692 | 0.22072 | 0 | 0.18739 | 0 | |
Darbības Izdevumi | -3.85524 | -2.76866 | -7.59245 | -9.28259 | -10.0257 | -14.7275 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 0.48458 | 0.56615 | 0.89453 | 0.98493 | 0.73171 | 1.65724 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -3.37067 | -2.20251 | -6.69791 | -8.29766 | -9.29396 | -13.0702 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -3.60874 | -1.33582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -3.60874 | -1.33582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Ārkārtas Posteņi Kopā | 0 | -0.8 | ||||
Neto Ienākumi | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -3.60874 | -1.33582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Atšķaidītie Neto Ienākumi | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Atšķaidītie Ienākumi par Akcijām | 36.5384 | 28.918 | 27.6733 | 27.0037 | 27.4716 | 27.8381 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.09877 | -0.04619 | -0.20568 | -0.30766 | -0.33945 | -0.46951 |
Atšķaidītā Normalizētā Peļņa par Akciju | -0.13612 | -0.14415 | -0.20568 | -0.30766 | -0.33945 | -0.46951 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 0.46052 | 0.93709 | 0.69293 | 0.31329 | 0.64843 |
Ienākumi | 0.46052 | 0.93709 | 0.69293 | 0.31329 | 0.64843 |
Cost of Revenue, Total | 0.39076 | 0.8295 | 0.39254 | 0.33163 | 0.40475 |
Bruto Peļņa | 0.06976 | 0.10759 | 0.30039 | -0.01834 | 0.24368 |
Kopējie Darbības Izdevumi | 3.78114 | 4.80417 | 4.01693 | 4.52908 | 3.39306 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 1.55401 | 1.74761 | 1.69284 | 1.70316 | 1.6557 |
Pētniecība un Attīstība | 1.8081 | 2.20924 | 1.90155 | 2.47348 | 1.34286 |
Procentu Izdevumi (Ienākumi) - Neto Darbība | 0.02827 | 0.01781 | 0.03 | 0.02081 | -0.01025 |
Darbības Izdevumi | -3.32062 | -3.86708 | -3.324 | -4.21579 | -2.74463 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | 0.02567 | 0.0209 | 0.0032 | 1.60746 | 0.00297 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Neto Ienākumi | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Atšķaidītie Neto Ienākumi | -3.29495 | -3.84617 | -1.71527 | -4.21386 | -2.49167 |
Atšķaidītie Ienākumi par Akcijām | 27.5333 | 27.6454 | 28.0792 | 28.0884 | 28.2513 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.11967 | -0.13913 | -0.06109 | -0.15002 | -0.0882 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | -0.11967 | -0.13913 | -0.06109 | -0.15002 | -0.0882 |
Other Operating Expenses, Total | 0 | 0 | 0 | ||
Citi, Neto | 1.60553 | -1.60553 | 0.25 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 57.6279 | 49.6158 | 42.7481 | 35.6392 | 29.7815 | 21.0083 |
Nauda un Īstermiņa Ieguldījumi | 48.9394 | 47.6851 | 41.2028 | 34.2227 | 29.0945 | 20.2603 |
Nauda un Ekvivalenti | 6.88936 | 5.78635 | 2.38631 | 4.82354 | 20.6371 | 15.7485 |
Īstermiņa Ieguldījumi | 42.05 | 41.8988 | 38.8164 | 29.3992 | 8.45745 | 4.51178 |
Debitoru Parādu Kopsumma, Neto | 1.08137 | 0.76087 | 1.11985 | 1.31244 | 0.40645 | 0.37221 |
Accounts Receivable - Trade, Net | 0.58821 | 0.27103 | 0.31874 | 0.55853 | 0.2942 | 0.27783 |
Prepaid Expenses | 0.24229 | 1.1698 | 0.42545 | 0.10411 | 0.28056 | 0.37583 |
Other Current Assets, Total | 7.36486 | 0 | ||||
Total Assets | 58.7004 | 50.7442 | 43.3008 | 37.4525 | 30.0724 | 21.2991 |
Long Term Investments | 1.06664 | 0.92265 | 0 | 1.51164 | 0.28471 | 0.28471 |
Other Long Term Assets, Total | 0.00585 | 0.20574 | 0.05214 | 0.05131 | 0.00623 | 0.00612 |
Total Current Liabilities | 1.01024 | 0.7689 | 0.84964 | 1.58803 | 1.62587 | 2.55572 |
Accounts Payable | 0.27906 | 0.52026 | 0.30906 | |||
Accrued Expenses | 0.389 | 0.14796 | 0.39958 | 0.566 | 0.48976 | 0.70956 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.34218 | 0.10068 | 0.141 | 1.02202 | 1.13612 | 1.84616 |
Total Liabilities | 1.01024 | 0.7689 | 0.84964 | 1.58803 | 1.62587 | 2.90866 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Total Equity | 57.6902 | 49.9753 | 42.4512 | 35.8645 | 28.4466 | 18.3905 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | |
Common Stock | 0.03893 | 0.03894 | 0.03897 | 0.03961 | 0.03975 | 0.04048 |
Additional Paid-In Capital | 93.2575 | 93.9136 | 94.3852 | 96.1059 | 98.0131 | 101.026 |
Retained Earnings (Accumulated Deficit) | -25.2043 | -27.3514 | -33.0431 | -41.3511 | -50.6763 | -63.7466 |
Treasury Stock - Common | -10.4019 | -16.6259 | -18.9299 | -18.9299 | -18.9299 | -18.9299 |
Other Equity, Total | 0 | |||||
Total Liabilities & Shareholders’ Equity | 58.7004 | 50.7442 | 43.3008 | 37.4525 | 30.0724 | 21.2991 |
Total Common Shares Outstanding | 32.3823 | 28.3278 | 26.7135 | 27.3592 | 27.4942 | 28.2292 |
Note Receivable - Long Term | 0.50062 | 0.25031 | 0 | |||
Other Liabilities, Total | 0.35294 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 27.9914 | 26.1564 | 23.5722 | 21.0083 | 16.2413 |
Nauda un Īstermiņa Ieguldījumi | 27.233 | 25.6007 | 22.7478 | 20.2603 | 15.4401 |
Nauda un Ekvivalenti | 13.0556 | 14.0188 | 13.6606 | 15.7485 | 12.419 |
Īstermiņa Ieguldījumi | 14.1774 | 11.5819 | 9.0872 | 4.51178 | 3.02106 |
Debitoru Parādu Kopsumma, Neto | 0.54216 | 0.45475 | 0.25443 | 0.37221 | 0.55705 |
Accounts Receivable - Trade, Net | 0.38496 | 0.29144 | 0.17963 | 0.27783 | 0.52815 |
Prepaid Expenses | 0.21619 | 0.10089 | 0.56997 | 0.37583 | 0.24417 |
Total Assets | 28.2822 | 26.4473 | 23.8631 | 21.2991 | 18.5302 |
Long Term Investments | 0.28471 | 0.28471 | 0.28471 | 0.28471 | 2.28283 |
Other Long Term Assets, Total | 0.00615 | 0.00617 | 0.00614 | 0.00612 | 0.0061 |
Total Current Liabilities | 2.59373 | 3.28849 | 1.96293 | 2.55572 | 1.82648 |
Accrued Expenses | 0.27767 | 0.5948 | 0.84245 | 0.70956 | 0.53301 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.31606 | 2.69368 | 1.12048 | 1.84616 | 1.29347 |
Total Liabilities | 2.59373 | 3.28849 | 1.96293 | 2.90866 | 2.1353 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 25.6885 | 23.1588 | 21.9001 | 18.3905 | 16.3949 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 0.03981 | 0.04033 | 0.04033 | 0.04048 | 0.04052 |
Additional Paid-In Capital | 98.5499 | 99.8658 | 100.322 | 101.026 | 101.523 |
Retained Earnings (Accumulated Deficit) | -53.9713 | -57.8175 | -59.5327 | -63.7466 | -66.2383 |
Treasury Stock - Common | -18.9299 | -18.9299 | -18.9299 | -18.9299 | -18.9299 |
Total Liabilities & Shareholders’ Equity | 28.2822 | 26.4473 | 23.8631 | 21.2991 | 18.5302 |
Total Common Shares Outstanding | 27.5542 | 28.0792 | 28.0792 | 28.2292 | 28.2642 |
Other Liabilities, Total | 0.35294 | 0.30882 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | -3.60874 | -2.13582 | -5.69176 | -8.30797 | -9.32527 | -13.0702 |
Nauda no Darbības | -6.03539 | -1.69117 | -4.40719 | -5.78289 | -6.57439 | -11.2769 |
Bezskaidras Naudas Preces | 0.26522 | 1.28542 | 1.16463 | 1.39701 | 1.76081 | 0.60508 |
Cash Taxes Paid | 0.0115 | 0.16374 | 0 | -0.50687 | -0.50062 | 0 |
Samaksātie Procenti Naudā | 0.00091 | |||||
Izmaiņas Apgrozāmajā Kapitālā | -2.69187 | -0.84078 | 0.11994 | 1.12806 | 0.99008 | 1.18823 |
Nauda no Ieguldījumu Darbībām | -42.556 | -0.81208 | 3.32832 | 7.70745 | 22.122 | 5.22159 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -42.556 | -0.81208 | 3.32832 | 7.70745 | 22.122 | 5.22159 |
Nauda no Darbībām ar Finansēšanu | -13.1204 | -6.22253 | -2.29954 | 0.55019 | 0.25547 | 1.23005 |
Naudas Plūsma Finansēšanas Posteņos | 0.04063 | |||||
Akciju Izsniegšana (Atkāpšanās), Neto | -13.161 | -6.22253 | -2.29954 | 0.55019 | 0.25547 | 1.23005 |
Parādu Izsniegšana (Atkāpšanās), Neto | 0 | |||||
Neto Izmaiņas Naudā | -61.7118 | -8.46787 | -3.40003 | 2.43723 | 15.8135 | -4.88857 |
Ārvalstu Valūtas Ietekme | 0.25792 | -0.02162 | -0.03752 | 0.01037 | -0.06326 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.29495 | -7.14112 | -8.85639 | -13.0702 | -2.49167 |
Cash From Operating Activities | -1.90651 | -4.30778 | -8.64188 | -11.2769 | -2.85038 |
Non-Cash Items | 0.51329 | 1.07275 | 0.04914 | 0.60508 | 0.45699 |
Changes in Working Capital | 0.87514 | 1.76059 | 0.16537 | 1.18823 | -0.81571 |
Cash From Investing Activities | -5.78394 | -3.28394 | 0.72159 | 5.22159 | -0.52085 |
Other Investing Cash Flow Items, Total | -5.78394 | -3.28394 | 0.72159 | 5.22159 | -0.52085 |
Cash From Financing Activities | 0.1158 | 0.98614 | 0.98555 | 1.23005 | 0.04235 |
Issuance (Retirement) of Stock, Net | 0.1158 | 0.98614 | 0.98555 | 1.23005 | 0.04235 |
Foreign Exchange Effects | -0.00683 | -0.01264 | -0.0417 | -0.06326 | -0.00057 |
Net Change in Cash | -7.58149 | -6.61822 | -6.97643 | -4.88857 | -3.32945 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
Emalfarb (Mark A) | Individual Investor | 15.8684 | 4532493 | 138478 | 2023-01-03 | LOW |
Francisco Trust | Corporation | 12.4235 | 3548528 | 0 | 2022-04-14 | LOW |
Bandera Partners LLC | Investment Advisor/Hedge Fund | 5.4858 | 1566908 | 0 | 2022-09-30 | LOW |
Chapin Davis Asset Management | Investment Advisor | 2.8695 | 819629 | 819629 | 2022-12-31 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.6382 | 753551 | 0 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.8822 | 251976 | 996 | 2022-09-30 | LOW |
Northeast Financial Consultants Inc | Investment Advisor | 0.8753 | 250000 | 0 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.736 | 210215 | 0 | 2022-09-30 | LOW |
Tarnok (Michael P) | Individual Investor | 0.6614 | 188929 | 0 | 2022-04-14 | LOW |
DIM Funds SICAV S.A. | Hedge Fund | 0.4796 | 137000 | 137000 | 2021-12-31 | |
Sage Mountain Advisors, LLC | Investment Advisor | 0.3731 | 106564 | 0 | 2022-12-31 | MED |
Herbst (Seth J. M.D.) | Individual Investor | 0.3676 | 105000 | 50000 | 2022-04-14 | MED |
Millennium Management LLC | Hedge Fund | 0.3525 | 100674 | -50298 | 2022-09-30 | HIGH |
Rawson (Ping Wang) | Individual Investor | 0.2971 | 84851 | 39351 | 2023-01-03 | LOW |
Hazelton (Joseph P) | Individual Investor | 0.2011 | 57448 | 57448 | 2023-01-03 | |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.198 | 56550 | 0 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.182 | 51974 | 1857 | 2022-09-30 | LOW |
Pekin Hardy Strauss Wealth Management | Investment Advisor | 0.1794 | 51240 | 0 | 2022-09-30 | LOW |
Perkins Capital Management, Inc. | Investment Advisor | 0.1684 | 48100 | 0 | 2022-12-31 | LOW |
Forefront Analytics, LLC | Investment Advisor/Hedge Fund | 0.142 | 40546 | -6225 | 2022-09-30 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com GroupTirgotāji
Ikmēneša aktīvie klienti
Ikmēneša ieguldījumu apjoms
Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Dyadic International, Inc. Company profile
Par Dyadic International, Inc.
Dyadic International, Inc. ir biotehnoloģiju platformas uzņēmums. Uzņēmums koncentrējas uz C1 platformas izstrādi, lai to izmantotu farmācijā cilvēkiem un dzīvniekiem visā pasaulē. C1 platformas tehnoloģijas pamatā ir Myceliopthora thermophila sēne, ko uzņēmums nosauca par C1. C1 gēnu ekspresijas platformu izmanto bioloģisko zāļu un vakcīnu atklāšanā, izstrādē un ražošanā. C1 tehnoloģija ir sēņu ekspresijas sistēma gēnu atklāšanai, attīstīšanai un enzīmu un citu proteīnu ražošanai. C1 tehnoloģija ir komerciāli pieejami risinājumi gēnu uzņemšanai un rūpniecisko procesu izstrādei, lai ražotu fermentu un citu olbaltumvielu produktu apjomus. Uzņēmums strādā arī pie ar COVID-19 saistītām vakcīnu un antivielu iespējām, tostarp COVID-19 vakcīnas kandidāta DYAI-100.
Industry: | Biotechnology & Medical Research (NEC) |
140 Intracoastal Pointe Dr Ste 404
JUPITER
FLORIDA 33477
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 485 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com